Inhibitor

(redirected from C1 INH)
Also found in: Dictionary, Thesaurus, Medical, Legal.

inhibitor

[in′hib·əd·ər]
(aerospace engineering)
A substance bonded, taped, or dip-dried onto a solid propellant to restrict the burning surface and to give direction to the burning process.
(chemistry)
A substance which is capable of stopping or retarding a chemical reaction; to be technically useful, it must be effective in low concentration.

Inhibitor

 

a circuit having m + n inputs and a single output, at which a signal can appear only when there are no signals on the m inputs (inhibiting). The other n inputs (principal) form one of the two logic connections, “AND” or “OR.” Inhibitors are used extensively in computers. They are very often understood to be a circuit having a single principal input and a single inhibiting input. A signal appears at the output of such a circuit when a signal is present on the principal input but there is none on the inhibiting input. Such an inhibitor is called an anticoincidence gate; its conventional representation is given in Figure 1.

Figure 1. Block diagram of an anticoincidence gate (inhibitor) with m — 1 and n 1:(A) principal input, (Q) inhibiting input, (Ga) anticoincidence gate

inhibitor

A substance added to paint to retard drying, skinning, mildew growth, etc. Also see corrosion inhibitor, inhibiting pigment, drying inhibitor.
References in periodicals archive ?
* Some tests should be run during a reaction if that is possible without endangering the patient (histamine, C4, and C1 INH levels).
Low levels of the C1 INH protein and decreased function of the protein distinguish type I HAE, which accounts for approximately 80% to 85% of all HAE cases.
HAE is a rare otosomal dominant disease caused by an inherited deficiency or dysfunction of the plasma protein C1 INH.
C1 INH eksikligini diger akut abdominal sendromlardan ayiran en onemli ozelik atesin, peritoneal bulgularin ve lokositozun eslik etmemesidir.
Tedavide uzun sureli profilaksi icin zayif androjenler (danazol ya da stanazolol), antifibrinolitik ajanlar (traneksamik asid, epsilon-aminokaproik asid) ve C1 INH konsantresi onerilmektedir (1,3,18).
C1 INH konsantresi hartada bir ya da iki kez olmak uzere 500 unite infuzyon seklinde bir yil ya da daha uzun sure kullanilabilir.